AI-Driven Digital Biomarkers in SaMD: Transforming Neurodegenerative Trials
Introduction to Digital Biomarkers and SaMD Digital biomarkers are objective, quantifiable physiological or behavioral measures captured through digital devices, offering new insights into disease progression and treatment efficacy. In the context of Software as a Medical Device (SaMD), these biomarkers are analyzed using adaptive AI algorithms, enabling real-time data processing and interpretation. This integration is […]
AI-Driven Digital Biomarkers in SaMD: Transforming Neurodegenerative Trials Read More »